British Journal of Cancer · 2000 · 32 citations · 36 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsCytogeneticsMolecular OncologyCancer CytogeneticsCancer GenomicsLoss Of HeterozygosityMolecular CytogeneticsPediatric Cancer GeneticsPediatric TumorsChromosome 14Q LossClinicopathologic FeaturesDeletion MappingDna In Situ HybridizationLoss Of Heterozygosity MappingMicrosatellite MarkersNeuroblastoma BiologyPulsed-field Gel Electrophoresis
Neuroblastoma (NB) is a well-known malignant disease in infants, but its molecular mechanisms have not yet been fully elucidated. To investigate the genetic contribution of abnormalities on the long arm of chromosome 14 (14q) in NB, we analysed loss of heterozygosity (LOH) in 54 primary NB samples using 12 microsatellite markers on 14q32. Seventeen (31%) of 54 tumours showed LOH at one or more of the markers analysed, and the smallest common region of allelic loss was identified between D14S62 and D14S987. This region was estimated to be 1-cM long from the linkage map. Fluorescence in situ hybridization also confirmed the loss. There was no statistical correlation between LOH and any clinicopathologic features, including age, stage, amplification of MYCN and ploidy. We further constructed a contig spanning the lost region using bacterial artificial chromosome and estimated this region to be approximately 1.1-Mb by pulsed-field gel electrophoresis. Our results will contribute to cloning and characterizing the putative tumour-associated gene(s) in 14q32 in NB.
36
A comprehensive genetic map of the human genome based on 5,264 microsatellites
Colette Dib, Sabine Fauré, Cécile Fizames et al. · Nature · 1996 · 3K citations
Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma
Nick Bown, Simon Cotterill, Maria Łastowska et al. · New England Journal of Medicine · 1999 · 546 citations
Life Sciences, Genetics, Oncology +17